Document Page: First | Prev | Next | All | Image | This Release | Search
File: 970107_sep96_decls35_0001.txt
Subject: BRIEFING ON PYRIDOSTIGMINE 17 AUG 90
Unit: OTSG
Parent Organization: HSC
Box ID: BX003204
Folder Title: BRIEFING ON PYRIDOSTIGMINE
Document Number: 1
Folder Seq #: 58
DEPARTMENT OF THE ARMY
OFFICE OF THE SURGEON GENERAL
$109 LEESBURG PIKE
FALLS CHURCH. VA 22041-3258
REPLY TO
DASG-RDZ ATTENTION OF 7 AUG it39U
MEM.ORANDUMFOR DEPARTMENTOFTHEARMY,OFFICEOFTHESURGEONGENERAL,ATTN:DASG-
HCD-D (MAJ ENG), 5109 LEESBURG PIKE, FALLS CHURCH, VA 22041-3258
SUBJECT: Briefing on pyridostigmine for MG Elam, Assistant Deputy Chief of Staff for Logistics
1. Dr. Foster in my office was called to a meeting (I 6 Aug 90 - 1400hrs) of Tri-service General Officees Comm' ,Uee
on CB Materiel Log@ics, chaired by MG Elam and supporting Operation Desert Shield.
a. He was asked for technical, medical use, operational, and logistics Jnforrnalion on the pyridostigmine
product available to the Tri-services.
b. He differed comment to OTSG and indicated that he would start a coordination effort to get the appropriate
person to brief the group.
2. COL Bob Mashburn, Executive Officer of DGSLOG Action Group on Chemical and Biological Materiel,
Indicated the following requirements to Dr. Foster In reference to the subject briefing.
a. All information should be the Tri-service position.
b. Briefing is scheduled for Thursday 23 August in the afternoon. Briefing should be geared to 5 m;nutes but
have backup charts ava;lab!e. The briefing hardcopy should be transmitted to COL Mashburrfs off ice by noon
Wednesday 22 August. No pre-briefings are required by the Logistics folks.
C. Three general topics should be covered.
What is pyridostigmine, how does ft work, what are the clinical uses, abuse potential etc?
ional scenario for pyddo use, who makes decision to use ft,
what are the differences in use among operating elements and among services?
- What is the current status of logistics of pyridosfigmino, what is the production base, what Is normal
production capacity & surge capacfty. are there off-shore sources and their capability, what is the current inventory
(millary wholesale, military retail. commercial, where are the stocks at this moment, how are the stocks issued from
storage through to the soldier etc?
3. COL Mashburn indicated that he has spoken with you. This memorandum provides you with information from
this office's contacts in order that you have a complete story with regard lo the subject briefing.
4. It I can be of assistance in this matter please or Dr. Foster (" 227-2915).
GE
Executive Assistant to the Assistant Surgeon
General for Research and Development
CF: SGRD-UMZ
SGRD-PLE
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 1 f:/Week-36/BX003204/BRIEFING ON PYRIDOSTIGMINE/briefing on pyridostigmine 17 aug 90:01029715472836
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003204
Unit = OTSG
Parent Organization = HSC
Folder Title = BRIEFING ON PYRIDOSTIGMINE
Folder Seq # = 58
Subject = BRIEFING ON PYRIDOSTIGMINE 17 AUG 90
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997